Press Release: Precision Neurodegenerative Disease Global Market Report 2024-2028: Key Growth Opportunities in GLP-1 RA and Insulin for AD and PD Patients and Neurotech-based Precision Therapies
Dublin, Sept. 26, 2024 (GLOBE NEWSWIRE) -- The "Precision Neurodegenerative Disease Market, Global, 2024-2028" report has been added to ResearchAndMarkets.com's offering. The rising global prevalence of neurodegenerative diseases (NDDs) is driving the shift from symptom-to-disease-modifying therapeutics that target unique pathological mechanisms, such as protein misfolding, neuroinflammation, and synaptic dysfunction, and customizing treatment based on unique…
Press Release: Precision Neurodegenerative Disease Global Market Report 2024-2028: Key Growth Opportunities in GLP-1 RA and Insulin for AD and PD Patients and Neurotech-based Precision Therapies - Newscast
Wed, 09 Oct 2024 07:50:00 GMT The London-based firm said it will use the funds to advance its gene therapy pipeline, including its lead program in IgA nephropathy.
Fri, 04 Oct 2024 05:47:00 GMT This helped to identify low-dose ketamine as a potential therapy for a rare disease, ADNP syndrome, part of the autism spectrum disorder. Precision Medicine in the Era of Rare, 2024 Play This ...
Thu, 03 Oct 2024 03:03:00 GMT DUBLIN--(BUSINESS WIRE)--The "Precision Neurodegenerative Disease Market, Global, 2024-2028" report has been added to ResearchAndMarkets.com's offering. The rising global prevalence of ...
Wed, 02 Oct 2024 12:59:00 GMT Precision Drilling Corporation (Precision) intends to release its 2024 third quarter results after the market closes on Tuesday, October 29, 2024, and has scheduled a conference call to begin at ...
Sun, 08 Sep 2024 16:59:00 GMT Inflammatory bowel diseases (IBD), such as Crohn's disease and ulcerative colitis ... the management of IBD and usher in a new era of precision medicine. More information: Yasuharu Maeda et ...
